LEF-1 expression has been previously utilised as a marker in different tumour entities like acute lymphoblastic leukaemia, oral squamous cell carcinoma, and colorectal cancer to identify Wnt/β-catenin activated tumours (44, 45). The gene discussed is LEF1; the disease is neoplasm.